These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 27140923)

  • 1. Characterization of Cas9-Guide RNA Orthologs.
    Braff JL; Yaung SJ; Esvelt KM; Church GM
    Cold Spring Harb Protoc; 2016 May; 2016(5):. PubMed ID: 27140923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted genome editing in human cells using CRISPR/Cas nucleases and truncated guide RNAs.
    Fu Y; Reyon D; Joung JK
    Methods Enzymol; 2014; 546():21-45. PubMed ID: 25398334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Planta Processing of the SpCas9-gRNA Complex.
    Mikami M; Toki S; Endo M
    Plant Cell Physiol; 2017 Nov; 58(11):1857-1867. PubMed ID: 29040704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frankenstein Cas9: engineering improved gene editing systems.
    Vos PD; Filipovska A; Rackham O
    Biochem Soc Trans; 2022 Oct; 50(5):1505-1516. PubMed ID: 36305591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly efficient gene inactivation by adenoviral CRISPR/Cas9 in human primary cells.
    Voets O; Tielen F; Elstak E; Benschop J; Grimbergen M; Stallen J; Janssen R; van Marle A; Essrich C
    PLoS One; 2017; 12(8):e0182974. PubMed ID: 28800587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of genome editing through CRISPR-Cas9 engineering.
    Zhang JH; Adikaram P; Pandey M; Genis A; Simonds WF
    Bioengineered; 2016 Apr; 7(3):166-74. PubMed ID: 27340770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPRseek: a bioconductor package to identify target-specific guide RNAs for CRISPR-Cas9 genome-editing systems.
    Zhu LJ; Holmes BR; Aronin N; Brodsky MH
    PLoS One; 2014; 9(9):e108424. PubMed ID: 25247697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction and Validation of Native and Engineered Cas9 Guide Sequences.
    Briner AE; Henriksen ED; Barrangou R
    Cold Spring Harb Protoc; 2016 Jul; 2016(7):. PubMed ID: 27371591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conditional Control of CRISPR/Cas9 Function.
    Zhou W; Deiters A
    Angew Chem Int Ed Engl; 2016 Apr; 55(18):5394-9. PubMed ID: 26996256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-Penetrating Peptide-Mediated Delivery of Cas9 Protein and Guide RNA for Genome Editing.
    Suresh B; Ramakrishna S; Kim H
    Methods Mol Biol; 2017; 1507():81-94. PubMed ID: 27832534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Target-dependent nickase activities of the CRISPR-Cas nucleases Cpf1 and Cas9.
    Fu BXH; Smith JD; Fuchs RT; Mabuchi M; Curcuru J; Robb GB; Fire AZ
    Nat Microbiol; 2019 May; 4(5):888-897. PubMed ID: 30833733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving CRISPR-Cas nuclease specificity using truncated guide RNAs.
    Fu Y; Sander JD; Reyon D; Cascio VM; Joung JK
    Nat Biotechnol; 2014 Mar; 32(3):279-284. PubMed ID: 24463574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [CRISPR/CAS9, the King of Genome Editing Tools].
    Bannikov AV; Lavrov AV
    Mol Biol (Mosk); 2017; 51(4):582-594. PubMed ID: 28900076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of an Inducible CRISPR/Cas9 System for CXCR4 Gene and Demonstration of its Effects on MKN-45 Cells.
    Peng Y; Yang T; Tang X; Chen F; Wang S
    Cell Biochem Biophys; 2020 Mar; 78(1):23-30. PubMed ID: 31875277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas9-Mediated Gene Knockout and Knockin Human iPSCs.
    Petazzi P; Menéndez P; Sevilla A
    Methods Mol Biol; 2022; 2454():559-574. PubMed ID: 33190185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR/Cas9 in Genome Editing and Beyond.
    Wang H; La Russa M; Qi LS
    Annu Rev Biochem; 2016 Jun; 85():227-64. PubMed ID: 27145843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulating CRISPR/Cas9 Function through Conditional Guide RNA Control.
    Brown W; Zhou W; Deiters A
    Chembiochem; 2021 Jan; 22(1):63-72. PubMed ID: 32833316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive Bioconductor ecosystem for the design of CRISPR guide RNAs across nucleases and technologies.
    Hoberecht L; Perampalam P; Lun A; Fortin JP
    Nat Commun; 2022 Nov; 13(1):6568. PubMed ID: 36323688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving CRISPR-Cas9 On-Target Specificity.
    Jamal M; Ullah A; Ahsan M; Tyagi R; Habib Z; Rehman K
    Curr Issues Mol Biol; 2018; 26():65-80. PubMed ID: 28879857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR-Cas9 off-targeting assessment with nucleic acid duplex energy parameters.
    Alkan F; Wenzel A; Anthon C; Havgaard JH; Gorodkin J
    Genome Biol; 2018 Oct; 19(1):177. PubMed ID: 30367669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.